An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we move away from sending confirmatory results via fax and implement sending them directly to your email.
Check out the Communication page for the complete details by clicking the link: Communications
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...